cymevene 500mg powder for concentrate for solution for infusion vials
neon healthcare ltd - ganciclovir sodium - powder for solution for infusion - 500mg
alimta 500mg powder for concentrate for solution for infusion vials
eli lilly and company ltd - pemetrexed disodium - powder for solution for infusion - 500mg
alimta 100mg powder for concentrate for solution for infusion vials
eli lilly and company ltd - pemetrexed disodium - powder for solution for infusion - 100mg
cresemba 200mg powder for concentrate for solution for infusion vials
pfizer ltd - isavuconazonium sulfate - powder for solution for infusion - 200mg
vancomycin 500mg powder for concentrate for solution for infusion vials
bowmed ibisqus ltd - vancomycin hydrochloride - powder for solution for infusion - 500mg
pemetrexed 100mg powder for concentrate for solution for infusion vials
seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 100mg
pemetrexed 500mg powder for concentrate for solution for infusion vials
seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 500mg
alimta powder for concentrate for solution for infusion
lilly france s.a.s. - pemetrexed (pemetrexed disodium heptahydrate) - powder for concentrate for solution for infusion - 500mg
sivextro 200mg powder for concentrate for solution for infusion vials
merck sharp & dohme ltd - tedizolid phosphate - powder for solution for infusion - 200mg
myozyme alglucosidase alfa-rch 50 mg / 10 ml powder for concentrate for solution for infusion
sanofi-aventis australia pty ltd - alglucosidase alfa, quantity: 52.5 mg - injection, powder for - excipient ingredients: monobasic sodium phosphate monohydrate; polysorbate 80; mannitol; nitrogen - myozyme (alglucosidase alfa-rch) is indicated for the long-term treatment of patients with a confirmed diagnosis of pompe disease (acid alfa-glucosidase deficiency).